Foghorn Therapeutics Inc. (FHTX) Key Metrics

2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue Per Share0.810.460.040.0100
Net Income Per Share-2.34-2.62-2.78-1.9-1.4-1.34
Operating Cash Flow Per Share-2.814.66-1.35-0.85-1.26-1.15
Free Cash Flow Per Share-2.844.63-1.44-1.29-1.28-1.23
Cash Per Share5.5815.374.155.050.412.04
Book Value Per Share-1.8402.613.97-2.39-2
Tangible Book Value Per Share-1.8402.613.97-2.39-2
Shareholders Equity Per Share-1.8402.613.97-2.39-2
Interest Debt Per Share1.071.241.622.260.470.38
Market Cap270.74M265.35M850.10M745.75M667.17M355.69M
Enterprise Value235.47M-28.94M807.30M734.95M668.82M322.70M
PE Ratio-2.75-2.44-8.24-10.69-12.91-13.51
Price to Sales Ratio7.9313.8644.511734.3100
P/OCF Ratio-2.291.37-16.92-23.84-14.4-15.7
P/FCF Ratio-2.271.38-15.87-15.71-14.1-14.7
PB Ratio-3.512369.238.785.1-7.58-9.06
PTB Ratio-3.512369.238.785.1-7.58-9.06
EV to Sales6.89-1.5612.051709.1900
Enterprise Value over EBITDA-2.250.25-8.39-11.05-13.71-12.61
EV to Operating Cash Flow-1.99-0.15-16.07-23.49-14.43-14.25
EV to Free Cash Flow-1.97-0.15-15.07-15.48-14.14-13.34
Earnings Yield-0.36-0.41-0.12-0.09-0.08-0.07
Free Cash Flow Yield-0.440.73-0.06-0.06-0.07-0.07
Debt to Equity-0.58459.880.60.56-0.19-0.18
Debt to Assets0.160.130.110.320.740.16
Net Debt to EBITDA0.342.590.450.16-0.031.29
Current Ratio4.111.039.4410.121.3311.68
Interest Coverage00-52.85-70-94.6-70.21
Income Quality1.2-1.780.50.450.910.86
Dividend Yield000000
Payout Ratio000000
SG&A to Revenue0.951.616.4726.1500
R&D to Revenue3.215.4960.9134.2200
Intangibles to Total Assets000000
Capex to Operating Cash Flow-0.010.01-0.07-0.52-0.02-0.07
Capex to Revenue0.040.062.5137.6300
Capex to Depreciation0.350.361.0312.21.44.07
Stock-based Comp to Revenue0.470.756.366.8900
Graham Number9.850.412.7613.028.697.77
ROIC-0.48-1.46-0.21-0.28-3.4-0.66
Return on Tangible Assets-0.34-0.27-0.2-0.27-2.31-0.61
Graham Net Net-3.075.64-1.172.08-2.59-2.16
Working Capital181.75M8.98M410.87M171.84M4.23M36.94M
Tangible Asset Value-77.19M112000.0096.87M146.19M-88.02M-39.27M
Net Current Asset Value-122.92M-58.97M36.66M81.28M-93.47M-41.93M
Invested Capital22465700058375000466949000234173000794600039033000
Average Receivables0.00150.00M150.00M0.000.00N/A
Average Payables5.84M4.62M3.75M3.56M2.73MN/A
Average Inventory0.000.000.000.000.00N/A
Days Sales Outstanding0083017.44000
Days Payables Outstanding20.83102772.52185.4923.27700.081939.6
Days of Inventory on Hand000000
Receivables Turnover000000
Payables Turnover17.5201.9715.680.520.19
Inventory Turnover000000
ROE1.28-972.09-1.07-0.480.590.67
Capex Per Share0.030.030.090.440.030.08

View Financial Metrics

VEON FTNT GRX NTZ ARGO VEEE TARS NXPI SLM GEV YELP HALL